New advances and challenges of targeting cancer stem cells

Nurmaa K. Dashzeveg; Rokana Taftaf; Erika K. Ramos; Luke Torre-Healy; Anastasia Chumakova; Daniel J. Silver; Tyler J. Alban; Maksim Sinyuk; Praveena S. Thiagarajan; Awad M. Jarrar; Soumya M. Turaga; Caner Saygin; Erin Mulkearns-Hubert; Masahiro Hitomi; Jeremy N. Rich; Stanton L. Gerson; Justin D. Lathia; Huiping Liu

doi:10.1158/0008-5472.CAN-17-0054

New advances and challenges of targeting cancer stem cells

Nurmaa K. Dashzeveg, Rokana Taftaf, Erika K. Ramos, Luke Torre-Healy, Anastasia Chumakova, Daniel J. Silver, Tyler J. Alban, Maksim Sinyuk, Praveena S. Thiagarajan, Awad M. Jarrar, Soumya M. Turaga, Caner Saygin, Erin Mulkearns-Hubert, Masahiro Hitomi, Jeremy N. Rich, Stanton L. Gerson, Justin D. Lathia, Huiping Liu^*

^*Corresponding author for this work

Pharmacology

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20–23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists.

Original language	English (US)
Pages (from-to)	5222-5227
Number of pages	6
Journal	Cancer Research
Volume	77
Issue number	19
DOIs	https://doi.org/10.1158/0008-5472.CAN-17-0054
State	Published - Oct 1 2017

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-17-0054

Cite this

Dashzeveg, N. K., Taftaf, R., Ramos, E. K., Torre-Healy, L., Chumakova, A., Silver, D. J., Alban, T. J., Sinyuk, M., Thiagarajan, P. S., Jarrar, A. M., Turaga, S. M., Saygin, C., Mulkearns-Hubert, E., Hitomi, M., Rich, J. N., Gerson, S. L., Lathia, J. D., & Liu, H. (2017). New advances and challenges of targeting cancer stem cells. Cancer Research, 77(19), 5222-5227. https://doi.org/10.1158/0008-5472.CAN-17-0054

@article{0c78e008a9b044ec87d65bb8560e4c2a,

title = "New advances and challenges of targeting cancer stem cells",

abstract = "The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20–23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists.",

author = "Dashzeveg, {Nurmaa K.} and Rokana Taftaf and Ramos, {Erika K.} and Luke Torre-Healy and Anastasia Chumakova and Silver, {Daniel J.} and Alban, {Tyler J.} and Maksim Sinyuk and Thiagarajan, {Praveena S.} and Jarrar, {Awad M.} and Turaga, {Soumya M.} and Caner Saygin and Erin Mulkearns-Hubert and Masahiro Hitomi and Rich, {Jeremy N.} and Gerson, {Stanton L.} and Lathia, {Justin D.} and Huiping Liu",

note = "Funding Information: The CSC 2016 and the meeting report were partially supported by NIH/NCIR13CA206377 (S.L. Gerson), P30 CA043703 (S.L. Gerson), and R00CA160638 (H. Liu). Publisher Copyright: {\textcopyright}2017 AACR.",

year = "2017",

month = oct,

day = "1",

doi = "10.1158/0008-5472.CAN-17-0054",

language = "English (US)",

volume = "77",

pages = "5222--5227",

journal = "Cancer Research",

issn = "0008-5472",

number = "19",

}

Dashzeveg, NK, Taftaf, R, Ramos, EK, Torre-Healy, L, Chumakova, A, Silver, DJ, Alban, TJ, Sinyuk, M, Thiagarajan, PS, Jarrar, AM, Turaga, SM, Saygin, C, Mulkearns-Hubert, E, Hitomi, M, Rich, JN, Gerson, SL, Lathia, JD & Liu, H 2017, 'New advances and challenges of targeting cancer stem cells', Cancer Research, vol. 77, no. 19, pp. 5222-5227. https://doi.org/10.1158/0008-5472.CAN-17-0054

TY - JOUR

T1 - New advances and challenges of targeting cancer stem cells

AU - Dashzeveg, Nurmaa K.

AU - Taftaf, Rokana

AU - Ramos, Erika K.

AU - Torre-Healy, Luke

AU - Chumakova, Anastasia

AU - Silver, Daniel J.

AU - Alban, Tyler J.

AU - Sinyuk, Maksim

AU - Thiagarajan, Praveena S.

AU - Jarrar, Awad M.

AU - Turaga, Soumya M.

AU - Saygin, Caner

AU - Mulkearns-Hubert, Erin

AU - Hitomi, Masahiro

AU - Rich, Jeremy N.

AU - Gerson, Stanton L.

AU - Lathia, Justin D.

AU - Liu, Huiping

N1 - Funding Information: The CSC 2016 and the meeting report were partially supported by NIH/NCIR13CA206377 (S.L. Gerson), P30 CA043703 (S.L. Gerson), and R00CA160638 (H. Liu). Publisher Copyright: ©2017 AACR.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20–23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists.

AB - The second International Cancer Stem Cell Conference in Cleveland, Ohio, on September 20–23, 2016, convened 330 attendees from academic, industrial, and clinical organizations. It featured a debate on the concepts and challenges of the cancer stem cells (CSC) as well as CSC-centered scientific sessions on clinical trials, genetics and epigenetics, tumor microenvironment, immune suppression, metastasis, therapeutic resistance, and emerging novel concepts. The conference hosted 35 renowned speakers, 100 posters, 20 short talks, and a preconference workshop. The reported advances of CSC research and therapies fostered new collaborations across national and international borders, and inspired the next generation's young scientists.

UR - http://www.scopus.com/inward/record.url?scp=85031492804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031492804&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-0054

DO - 10.1158/0008-5472.CAN-17-0054

M3 - Article

C2 - 28928129

AN - SCOPUS:85031492804

SN - 0008-5472

VL - 77

SP - 5222

EP - 5227

JO - Cancer Research

JF - Cancer Research

IS - 19

ER -

New advances and challenges of targeting cancer stem cells

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this